A phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancer - Breast Cancer I

Karasawa Kumiko0 个研究点目标入组 20 人开始时间: 2019年2月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Biopsy- or histology-proven invasive ductal carcinoma of the breast (usual type)
•2. A single tumor with an extent of less than 2 cm on MRI (Stage I disease in UICC)
•3. No extensive lymphatic infiltration (LVSI), no extensive intraductal extension (EIC). Estrogen receptor (ER) positive and HER2-negative.
•4. PS is 0-2.
•5. A woman age of 60 or over.
•6. Expected to survive for more than 6 months.
•7. The person wishes to participate in the exam and has obtained written consent.

•1. Have serious uncontrollable complications (eg, uncontrollable cardiopulmonary disease, intractable infections, uncontrollable psychiatric disorders, etc.).
•2. Has a history of treatment such as surgery, chemotherapy, endocrine therapy, and molecular-targeted drugs for ipsilateral breast cancer.
•3. Systemic drug therapy for active cancers (including contralateral breast cancer).
•4. Tumor infiltrates chest wall or skin.
•5. The distance between the tumor and the skin, including the intraductal extension that can be identified on the MRI image, is within 5 mm.
•6. There is a history of radiation therapy at the tumor site.
•7. Ductal carcinoma in situ (pure DCIS).
•8. The attending physician considers it inappropriate due to medical, psychological or other factors.

发起方

Karasawa Kumiko